For the Quarter Ending March 2026
Lincomycin Hydrochloride Prices in North America
- In United States, the Lincomycin Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by constrained supply.
- Producer prices rose 4.0% year-over-year in March 2026, reflecting elevated input costs for API manufacturing.
- Headline consumer inflation reached 3.3% in March 2026, increasing operational expenses across pharmaceutical supply chains.
- The Lincomycin Hydrochloride Demand Outlook strengthened as veterinary swine sector feed costs decreased in February 2026.
- Active pharmaceutical ingredient inventories tightened significantly due to global supply chain vulnerabilities in January 2026.
- Retail sales grew 4.0% year-over-year in March 2026, supporting steady downstream consumption at retail pharmacies.
- The manufacturing index expanded while industrial production grew 0.7% in March 2026, indicating robust activity.
- The Lincomycin Hydrochloride Production Cost Trend stabilized as corn fermentation feedstock costs depressed in February 2026.
- The Lincomycin Hydrochloride Price Forecast remained bullish as API imports faced logistical risks in January 2026.
Why did the price of Lincomycin Hydrochloride change in March 2026 in North America?
- Domestic antibiotic manufacturing capacity remained heavily constrained amid ongoing pharmaceutical shortages in January 2026.
- Producer prices increased 4.0% in March 2026, passing elevated input costs to chemical buyers.
- Natural gas prices rose sharply amid severe winter weather and inventory withdrawals in January 2026.
Lincomycin Hydrochloride Prices in APAC
- In China, the Lincomycin Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by elevated feedstock costs.
- Production costs increased as the Producer Price Index rose 0.5% in March 2026, elevating synthesis expenses.
- The Consumer Price Index grew 1.0% in March 2026, supporting stable pork prices and veterinary demand.
- Industrial production expanded 5.7% in March 2026, reflecting high utilization across pharmaceutical fermentation facilities domestically.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, pressuring premium meat consumption.
- Consumer confidence stood at 91.6 in February 2026, indicating cautious household spending that restricted livestock farming.
- The Lincomycin Hydrochloride Production Cost Trend pointed upward as soybean meal and corn starch rose in Q1 2026.
- The Lincomycin Hydrochloride Demand Outlook strengthened in Q1 2026 as pharmaceutical exports surged and swine slaughter expanded.
- The Lincomycin Hydrochloride Price Forecast stayed elevated in March 2026 as the Manufacturing Index expanded.
Why did the price of Lincomycin Hydrochloride change in March 2026 in APAC?
- Tightened soybean meal and corn starch inventories drove fermentation feedstock costs higher in Q1 2026.
- Expanded swine slaughter rates and surging pharmaceutical exports strengthened overall downstream demand during Q1 2026.
- The Producer Price Index rose 0.5% in March 2026, directly increasing factory-gate API synthesis expenses.
Lincomycin Hydrochloride Prices in Europe
- In Germany, the Lincomycin Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by surging energy costs.
- The 2.7% CPI increase in March 2026 elevated utility-intensive fermentation costs, pushing the Lincomycin Hydrochloride Production Cost Trend upward.
- Conversely, upstream producer prices fell 0.2% in March 2026, slightly easing raw material extraction costs for Lincomycin Hydrochloride.
- The Manufacturing Index expanded in March 2026, indicating increased pharmaceutical formulation activity and supporting the Lincomycin Hydrochloride Demand Outlook.
- Industrial production remained flat at 0.0% in February 2026, keeping Lincomycin Hydrochloride supply expansion balanced within the broader pharmaceutical sector.
- Retail sales grew 0.7% in February 2026, sustaining livestock farming needs and boosting veterinary Lincomycin Hydrochloride demand.
- A stable 4.2% unemployment rate in February 2026 ensured consistent household spending on protein diets, supporting Lincomycin Hydrochloride usage.
- Consumer confidence dropped to -24.7 in March 2026, squeezing livestock margins and negatively impacting the Lincomycin Hydrochloride Price Forecast.
Why did the price of Lincomycin Hydrochloride change in March 2026 in Europe?
- Fermentation energy costs spiked in March 2026 as European natural gas benchmark prices surged significantly.
- Agricultural fermentation feedstock procurement costs fluctuated in March 2026 due to unprecedented maritime trade disruptions.
- European natural gas demand weakened in March 2026 in response to higher prices and milder weather.
For the Quarter Ending December 2025
Lincomycin Hydrochloride Prices in North America
- In the United States, the Lincomycin Hydrochloride Price Index rose quarter-over-quarter in Q4 2025, driven by increasing production costs.
- Lincomycin Hydrochloride production costs rose in Q4 2025, influenced by a 3.0% PPI increase in November 2025.
- Industrial electricity rates strengthened significantly in November 2025, contributing to higher Lincomycin Hydrochloride production expenses.
- Demand for Lincomycin Hydrochloride was supported by a 2.0% industrial production increase in December 2025, especially in veterinary sectors.
- The Lincomycin Hydrochloride price forecast indicates continued upward pressure from elevated natural gas prices in Q4 2025.
- Overall US economic activity experienced robust expansion in Q4 2025, supporting general market conditions for Lincomycin Hydrochloride.
- Consumer spending, with retail sales up 3.3% in November 2025, positively influenced veterinary Lincomycin Hydrochloride demand.
- The broader chemical industry navigated a prolonged downcycle throughout 2025, contributing to general cost pressures for Lincomycin Hydrochloride.
Why did the price of Lincomycin Hydrochloride change in December 2025 in North America?
- Production costs rose due to a 2.7% CPI increase in December 2025, impacting raw material expenses.
- Elevated natural gas prices in Q4 2025 and strengthened industrial electricity rates in November 2025 increased operational costs.
- Strong consumer spending, with retail sales up 3.3% in November 2025, supported veterinary Lincomycin Hydrochloride demand.
Lincomycin Hydrochloride Prices in APAC
- In China, the Lincomycin Hydrochloride Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices in December 2025.
- Lincomycin Hydrochloride production costs decreased in December 2025, as the Producer Price Index (PPI) declined by 1.9% year-over-year.
- Demand for Lincomycin Hydrochloride was supported by an expanding Manufacturing Index in December 2025, indicating industrial growth.
- Industrial Production in China rose by 5.2% year-over-year in December 2025, bolstering overall market activity.
- Subdued consumer spending, with retail sales growing only 0.9% in December 2025, tempered Lincomycin Hydrochloride demand.
- China's pharmaceutical market experienced rapid growth throughout 2025, driven by rising chronic diseases and an aging population.
- Government investment in the pharmaceutical industry contributed to market expansion in China during 2025, supporting Lincomycin Hydrochloride.
- China's medicine exports, including active pharmaceutical ingredients, saw steadily increasing scales in the first 11 months of 2025.
Why did the price of Lincomycin Hydrochloride change in December 2025 in APAC?
- Producer Price Index (PPI) declined by 1.9% in December 2025, reducing Lincomycin Hydrochloride manufacturing costs.
- Subdued consumer spending, with retail sales growing only 0.9% in December 2025, impacted demand.
- Weak inflationary pressure, indicated by a 0.8% Consumer Price Index (CPI) in December 2025.
Lincomycin Hydrochloride Prices in Europe
- In Germany, Lincomycin Hydrochloride prices rose in Q4 2025, driven by persistent production cost pressures.
- Production costs increased due to elevated energy and carbon costs for industrial consumers in Q4 2025.
- Producer prices declined 2.5% year-over-year in December 2025, easing broader industrial input costs.
- Consumer Price Index rose 1.8% year-over-year in December 2025, indicating stable purchasing power.
- Demand was supported by moderate pharmaceutical market growth and robust prescription demand in Q4.
- Retail sales increased 1.1% year-over-year in November 2025, supporting demand for animal products.
- The German Manufacturing Index contracted in December 2025, indicating a slowdown in economic activity.
- Consumer confidence declined to -17.5 in December 2025, with unemployment at 6.2%.
- Industrial production grew 0.8% year-over-year in October 2025, supporting stable manufacturing activity.
- API imports faced margin pressure in Germany in Q4 2025, due to the EU Carbon Border Tax.
Why did the price of Lincomycin Hydrochloride change in December 2025 in Europe?
- Elevated energy and carbon costs persisted in Q4 2025, increasing production expenses.
- Pharmaceutical supply chain vulnerabilities and drug shortages impacted availability in Q4 2025.
- Robust prescription medicine demand and moderate pharmaceutical market growth supported demand.
For the Quarter Ending September 2025
Lincomycin Hydrochloride Prices in North America
- In the United States, the Lincomycin Hydrochloride Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs.
- Production costs increased from a 2.6% PPI rise in August 2025 and strengthened natural gas prices in Q3 2025.
- Demand outlook was supported by a 5.42% retail sales increase in September 2025, boosting animal product consumption.
- US pharmaceutical market sentiment strengthened in Q3 2025, with surging drug approvals impacting Lincomycin Hydrochloride demand.
- Industrial electricity prices rose in September 2025, increasing manufacturing expenses for Lincomycin Hydrochloride producers.
- Overall chemical industry inventories remained elevated in Q3 2025, while manufacturing activity contracted.
- A 3.0% CPI increase in September 2025 indicated general inflation, raising operational costs for Lincomycin Hydrochloride manufacturers.
Why did the price of Lincomycin Hydrochloride change in September 2025 in North America?
- Production costs rose due to a 2.6% PPI increase in August 2025 and strengthened natural gas prices in Q3 2025.
- Demand was supported by a 5.42% retail sales increase in September 2025 and robust pharmaceutical market sentiment.
- General inflation, indicated by a 3.0% CPI increase in September 2025, raised overall operational expenses.
Lincomycin Hydrochloride Prices in Europe
- In Germany, the Lincomycin Hydrochloride Price Index fell quarter-over-quarter in Q3 2025, influenced by easing producer prices and contracting industrial activity.
- Lincomycin Hydrochloride production costs faced mixed pressures; producer prices decreased by 1.7% year-on-year in September 2025.
- Moderate inflation, with CPI at 2.4% year-on-year in September 2025, contributed to rising raw material and industrial electricity costs.
- Demand for Lincomycin Hydrochloride was supported by moderate pharmaceutical market growth and robust healthcare spending in Q3 2025.
- Overall industrial production declined by 1.0% year-on-year in September 2025, and the Manufacturing Index contracted, dampening broader demand.
- A low unemployment rate of 3.9% in September 2025 supported purchasing power, yet negative consumer confidence (-23.6) limited discretionary spending.
- German chemical export orders trended weak in Q3 2025, with non-European market sales falling significantly, impacting trade flows.
- The Lincomycin Hydrochloride price forecast suggests continued stability with potential downward pressure due to weak industrial output and trade.
Why did the price of Lincomycin Hydrochloride change in September 2025 in Europe?
- Producer prices decreased by 1.7% year-on-year in September 2025, easing Lincomycin Hydrochloride input costs.
- Manufacturing Index contracted and industrial production declined 1.0% in September 2025, reducing demand.
- Robust healthcare spending and moderate pharmaceutical market growth in Q3 2025 provided demand resilience.
Lincomycin Hydrochloride Prices in APAC
- In China, the Lincomycin Hydrochloride Price Index rose quarter-over-quarter in Q3 2025, driven by strengthening API export prices.
- Lincomycin Hydrochloride production costs increased during Q3 2025 due to elevated natural gas and global oil prices.
- Demand for Lincomycin Hydrochloride grew steadily in Q3 2025, supported by rising domestic generic drug consumption.
- In September 2025, the Consumer Price Index declined by 0.3%, indicating deflationary pressures on market sentiment.
- The Producer Price Index fell by 2.3% in September 2025, suggesting weak industrial demand and reduced pricing power.
- China's industrial production increased by 6.5% in September 2025, supporting economic growth and pharmaceutical demand.
- Retail sales grew by 3.0% in September 2025, reflecting stable consumer demand for human medicine applications.
- The Manufacturing Index contracted in September 2025, signaling a slowdown in the broader manufacturing sector.
- Consumer confidence remained cautious at 89.6 in September 2025, potentially impacting overall healthcare spending.
Why did the price of Lincomycin Hydrochloride change in September 2025 in APAC?
- Strengthening API export prices in China supported the Lincomycin Hydrochloride index in Q3 2025.
- Elevated natural gas and global oil prices increased Lincomycin Hydrochloride production costs.
- Steady API demand growth from generic and innovative drugs bolstered the Lincomycin Hydrochloride market.
For the Quarter Ending December 2022
North America
In the fourth quarter of 2022, Lincomycin Hydrochloride API costs decreased somewhat in North America, with CFR Los Angeles values dropping from $41850/mt to $41560/mt from October to December by 0.69%. The first week of October saw a delay in the imports of Lincomycin Hydrochloride due to a one-week holiday in exporting powerhouse China, but local demand was still strong.
Despite this, the domestic retailers' significant stock holdings and low demand for Lincomycin Hydrochloride during the second half kept prices in the US on the down. However, the protracted supply chain did start to mend as the economy expanded, and the port backlog dramatically decreased in November.
Asia Pacific
During the fourth quarter of 2022, the price of Lincomycin Hydrochloride across the Asia Pacific region displayed a downward price trajectory. Between October and December, FOB Shanghai prices in China decreased from $37980/mt to $36750/mt. Orders for Lincomycin Hydrochloride for China's API market slightly decreased during the first week of October Due to the closure of production facilities for the Golden Week. Domestic merchants encountered a lot of contradicting signals following a one-week holiday and the market's reopening, which made it difficult for the players to keep up with the slow development seen in the downstream industries. Offtakes in the pharmaceutical sectors remained consistent in terms of demand throughout the quarter. Due to criticism and widespread displeasure in the country, government authorities changed their zero-covid regulations, making the country vulnerable once more in the second half of the fourth quarter of 2022.
Europe
In Europe, the German market for Lincomycin Hydrochloride followed the same pattern as North America and Asia. The CFR Hamburg prices were resolved at $38450/mt in October and $38040/mt in December, indicating a downward trend. Offtakes were higher in the first part of the quarter than they were in December as a result of the unexpected rise in coronavirus infections, which caused a decrease in global demand in the latter weeks of December. But the economy as a whole continued to suffer from factors like COVID accidents and the conflict between Russia and Ukraine. Along with the easing of supply chain concerns, the CPI in Germany fell at the end of the year.
